Physician

Sowjanya Reganti, M.D.,

According to 2025 Medicare claims, Sowjanya Reganti, M.D., (NPI: 1356482020) practices hematology/oncology in the Reno, NV market, with the plurality of this provider's patient population coming from Washoe, NV. This provider's primary affiliated billing organization is JOHN A SHIELDS MD AND STEVEN A SCHIFF MD A PROFESSIONAL CORPORATION (NPI: 1861514580; TIN: 880152239) and primary practice location at 89511-2250. Reganti is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Reganti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 762 traditional Medicare patients, billed 133,697 HCPCS/CPT codes, and received $2,500,566 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,516 prescription claims across 497 beneficiaries totaling $3,687,427 in drug costs, led by Verzenio (Abemaciclib). DME data shows 56 claims. Open Payments data shows 54 records totaling $30,483. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,431,705 to $2,500,566. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,715,422 to $3,687,427. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	536	111,253	$1,431,705
2016	620	169,002	$1,997,161
2017	584	102,752	$1,748,055
2018	670	103,320	$2,070,952
2019	815	140,636	$2,786,772
2020	853	146,004	$2,861,517
2021	840	115,226	$2,332,508
2022	769	125,604	$2,212,959
2023	761	123,286	$2,626,611
2024	762	133,697	$2,500,566

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	262	1,470	$1,715,422
2016	308	1,841	$1,952,505
2017	348	1,962	$2,454,946
2018	372	1,959	$2,311,570
2019	443	2,094	$2,880,430
2020	474	2,415	$4,271,481
2021	523	2,418	$4,280,910
2022	515	2,357	$3,998,146
2023	491	2,319	$3,996,642
2024	497	2,516	$3,687,427

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	25	126	$11,603
2016	26	170	$31,404
2017	N/R	85	$16,665
2018	N/R	129	$13,570
2019	N/R	66	$5,368
2020	N/R	11	$227
2021	N/R	12	$1,363
2022	N/R	12	$1,433
2023	N/R	11	$1,865
2024	N/R	56	$4,207

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	270	507	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	485	978	$90
80053	Blood test, comprehensive group of blood chemicals	285	602	$10
36415	Insertion of needle into vein for collection of blood sample	384	842	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	398	949	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Verzenio	Abemaciclib	44	1,232	$637,276
Pomalyst	Pomalidomide	17	476	$385,916
Jakafi	Ruxolitinib Phosphate	31	930	$359,131
Imbruvica	Ibrutinib	13	364	$241,433
Ibrance	Palbociclib	13	364	$217,232

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	11	$2,330
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	19	$826
J8521	Capecitabine, oral, 500 mg	N	N/R	13	$571
E0657	Segmental pneumatic appliance for use with pneumatic compressor, chest	Y	N/R	13	$479

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	47	$8,147	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	7	$22,336	PFIZER INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sowjanya Reganti, M.D., ?

Tedicare shows public-source Medicare data for Sowjanya Reganti, M.D., (NPI 1356482020), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sowjanya Reganti, M.D., have ACO affiliation data?

Sowjanya Reganti, M.D., is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Sowjanya Reganti, M.D., ?

Sowjanya Reganti, M.D., is linked to JOHN A SHIELDS MD AND STEVEN A SCHIFF MD A PROFESSIONAL CORPORATION (billing NPI 1861514580) in the available physician profile data.

Does Sowjanya Reganti, M.D., have Open Payments data?

Sowjanya Reganti, M.D., has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.